On April 2020, 4, the startup company "FunPep" (Ibaraki City, Osaka Prefecture) from Osaka University participated in the development of a new coronavirus preventive DNA vaccine jointly promoted by Osaka University and AnGes MG, Inc. Announced.
Osaka University and AnGes announced on March 3 that they will start developing a preventive DNA vaccine against the new coronavirus "COVID-9".Currently, we are working on the development of next-generation vaccines using peptide technology.
FunPep has "peptide technology (AJP001)" that enhances the effect of vaccines, which is the research result of Osaka University, and "peptide vaccine (antibody-induced peptide)" using this technology has already been clinically tested overseas. There is.By adding this peptide technology to the DNA vaccine currently under development, it is expected that the antibody output will be improved.
With the participation of FunPep, it is expected that the dose and frequency of the vaccine will be reduced, and that the vaccine will have the added benefits of a strong infection-preventing effect and suppression of aggravation.
